SUNESIS PHARMACEUTICALS INC Human Resources Contracts & Agreements
69 Contracts & Agreements
- Bonus & Incentive Agreements (27 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (8)
- Consulting Agreements (5)
- Employment Agreements (8)
- Retention Agreements (1)
- Separation Agreements (1)
- Severance Agreements (16)
- Transition Agreements (2)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on August 14, 2024)
- Employment Agreement by and between the Company and Michael Faerm, dated as of May 11, 2024 (Filed With SEC on May 14, 2024)
- Consulting Agreement by and between the Company and Daniel Chevallard, dated March 20, 2024 (Filed With SEC on May 9, 2024)
- Employment Agreement by and between the Company and Melody Burcar, dated September 30, 2022, as amended by the Amendment to Employment Agreement by and between the Company and... (Filed With SEC on March 20, 2024)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on August 14, 2023)
- Consulting Agreement between the Company and Lisa Rojkjaer, M.D., dated May 5, 2023 (Filed With SEC on May 5, 2023)
- Separation Agreement and Release by and between the Company and Ivor Royston, dated September 15, 2022 (Filed With SEC on September 19, 2022)
- Executive Employment Agreement by and between the Company and Mark Rothera, dated September 15, 2022 (Filed With SEC on September 19, 2022)
- Executive Incentive Compensation Plan (Filed With SEC on March 17, 2022)
- Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Lisa Rojkjaer, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)
- Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Daniel Chevallard, dated August 12, 2021 (Filed With SEC on August 12, 2021)
- Amendment to Employment Agreement between Viracta Therapeutics, Inc. and Ivor Royston, M.D., dated August 12, 2021 (Filed With SEC on August 12, 2021)
- 2021 Inducement Equity Incentive Plan and form of agreement thereunder (Filed With SEC on August 12, 2021)
- Amended and Restated Outside Director Compensation Plan (Filed With SEC on May 13, 2021)
- Form of Executive Severance Benefits Agreement between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on December 22, 2020)
- Form of Retention Benefits Letter between Sunesis Pharmaceuticals, Inc. and certain officers (Filed With SEC on November 30, 2020)
- Executive Severance Benefits Agreement, dated May 4, 2020, by and between the Registrant and Tina Gullotta (Filed With SEC on August 11, 2020)
- Consulting Agreement, dated May 2, 2020, by and between the Registrant and William P. Quinn (Filed With SEC on August 11, 2020)
- Sunesis Pharmaceuticals, Inc. 2020 Bonus Program (Filed With SEC on February 14, 2020)
- Sunesis Pharmaceuticals, Inc. 2019 Bonus Program (Filed With SEC on February 4, 2019)
- Executive Severance Benefits Agreement, dated November 30, 2017, by and between the Registrant and William P. Quinn (Filed With SEC on March 9, 2018)
- Sunesis Pharmaceuticals, Inc. 2018 Bonus Program (Filed With SEC on February 5, 2018)
- Transition and Resignation Agreement, by and between Sunesis Pharmaceuticals, Inc. and Eric Bjerkholt, dated as of April 21, 2017 (Filed With SEC on July 27, 2017)
- SUNESIS PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 8, 2017)
- SUNESIS PHARMACEUTICALS, INC. 2017 BONUS PROGRAM (Filed With SEC on March 27, 2017)
- Non-Employee Director Compensation Information (Filed With SEC on July 29, 2016)
- THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on May 9, 2016)
- THIRD AMENDED AND RESTATED EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on May 9, 2016)
- Non-Employee Director Compensation Information (Filed With SEC on May 9, 2016)
- SUNESIS PHARMACEUTICALS, INC. 2016 BONUS PROGRAM (Filed With SEC on March 28, 2016)
- SUNESIS PHARMACEUTICALS, INC. 2015 BONUS PROGRAM (Filed With SEC on March 23, 2015)
- SUNESIS PHARMACEUTICALS, INC. 2014 BONUS PROGRAM (Filed With SEC on March 24, 2014)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 6, 2014)
- Non-Employee Director Compensation Information (Filed With SEC on August 2, 2013)
- SUNESIS PHARMACEUTICALS, INC. 2013 BONUS PROGRAM (Filed With SEC on March 27, 2013)
- SUNESIS PHARMACEUTICALS, INC. AMENDMENT TO EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 13, 2013)
- SUNESIS PHARMACEUTICALS, INC. 2012 BONUS PROGRAM (Filed With SEC on March 28, 2012)
- SUNESIS PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT GRANT NOTICE 2011 EQUITY INCENTIVE PLAN (Filed With SEC on March 14, 2012)
- SUNESIS PHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2011 EQUITY INCENTIVE PLAN) (Filed With SEC on March 14, 2012)
- EXECUTIVE SEVERANCE BENEFITS AGREEMENT (Filed With SEC on March 14, 2012)
